
Sign up to save your podcasts
Or
Dr Benjamin Levy from Johns Hopkins Sidney Kimmel Cancer Center at Sibley Memorial in Washington, DC, discusses important efficacy and safety data from 2024 related to the use of approved and investigational therapies for localized and advanced non-small cell lung cancer without a targetable mutation.
CME information and select publications here.
4.4
3030 ratings
Dr Benjamin Levy from Johns Hopkins Sidney Kimmel Cancer Center at Sibley Memorial in Washington, DC, discusses important efficacy and safety data from 2024 related to the use of approved and investigational therapies for localized and advanced non-small cell lung cancer without a targetable mutation.
CME information and select publications here.
17 Listeners
14 Listeners
66 Listeners
13 Listeners
70 Listeners
0 Listeners
6 Listeners
318 Listeners
40 Listeners
111 Listeners
58 Listeners
122 Listeners
46 Listeners
28 Listeners
60 Listeners
86 Listeners
181 Listeners